The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Open accessAbstract
BACKGROUND: Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease. It has been debated whether patients with diabetes who have not had myocardial infarctions should be treated as aggressively for cardiovascular risk factors as patients who have had myocardial infarctions. METHODS: To address this issue, we compared the seven-year incidence of myocardial infarction (fatal and nonfatal) among 1373 nondiabetic subjects with the incidence among 1059 diabetic subjects, all from a Finnish population-based study. RESULTS: The seven-year incidence rates of myocardial infarction in nondiabetic subjects with and without prior myocardial infarction at base line were 18.8 percent and 3.5 percent, respectively (P<0.001). The seven-year incidence rates of myocardial infarction in diabetic subjects with and without prior myocardial infarction at base line were 45.0 percent and 20.2 percent, respectively (P<0.001). The hazard ratio for death from coronary heart disease for diabetic subjects without prior myocardial infarction as compared with nondiabetic subjects with prior myocardial infarction was not significantly different from 1.0 (hazard ratio, 1.4; 95 percent confidence interval, 0.7 to 2.6) after adjustment for age and sex, suggesting similar risks of infarction in the two groups. After further adjustment for total cholesterol, hypertension, and smoking, this hazard ratio remained close to 1.0 (hazard ratio, 1.2; 95 percent confidence interval, 0.6 to 2.4). CONCLUSIONS: Our data suggest that diabetic patients without previous myocardial infarction have as high a risk of myocardial infarction as nondiabetic patients with previous myocardial infarction. These data provide a rationale for treating cardiovascular risk factors in diabetic patients as aggressively as in nondiabetic patients with prior myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“diabetes-related morbidity and mortality is primarily due to cardiovascular complications [17,18,19].”
From Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Patients with type 2 diabetes mellitus have an increased incidence of atherosclerotic cardiovascular disease.1–4”
From Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (2010) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, T2DM is associated with low-grade inflammation,382, 383 cardiovascular disease,384, 385 nephropathy386, 387 and alterations in the secretion of various hormones, including IL-6, IL-18, tumor necrosis factor-α,388 adiponectin and leptin,389 neuropeptides,390 ghrelin391, 392 and the incretins GLP-1 and GIP.219, 220, 221, 222, 223”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [384]
In the citing paper
“In contrast, patients who did not have T2DM, the death rates due to cardiovascular causes were 2.1 and 15.9%, respectively.”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [6]
In the citing paper
“Furthermore, people with T2DM are disproportionately affected by CVD compared with non-diabetic subjects [6].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [6]
In the citing paper
“In persons with T2DM, the death rates were 15.4% for those with no prior myocardial infarction (MI) and 42.0% in patients having a history of MI.”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [6]
In the citing paper
“It has been stated that type 2 diabetic patients without a previous history of myocardial infarction have the same risk of coronary artery disease (CAD) as non-diabetic subjects with a history of myocardial infarction [69].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Self-citationSacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Self-citationDiabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Kannel, W. B., & McGee, D. L. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.120 · Cited by 1,203
Diabetes and atherosclerosis: An epidemiologic view
Pyörälà, K., Laakso, M., & Uusitupa, M. I. J. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030206 · Cited by 912
Self-citationPekkanen, J., Linn, S., Heiss, G., Suchindran, C. M., Leon, A., Rifkind, B. M., & Tyroler, H. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222403 · Cited by 821
Research works printed but not linked: 5
- 1993, JAMA, 209, 3015
- 1994, Lancet, 344, 1383
- 1985, WHO Tech Rep Ser, 727, 1
- Walker AE, 1981, Stroke, 12, I
- D'Agostino RB Jr, Mykkänen L, Goff D, et al. Atherosclerosis in type 2 diabetic and non-diabetic subjects with and without previous myocardial infarction: the Insulin Resistance Atherosclerosis Study (IRAS). Presented at the American Heart Association 38th Annual Conference on Cardiovascular Disease: Epidemiology and Prevention, Santa Fe, N.M., March 18–21, 1998. abstract.
Cited by
Sorted by citations
Items 101–200 of 229
Impact of Diet Composition on Blood Glucose Regulation
Russell, W. R., Baka, A., Björck, I., Delzenne, N., Gao, D., Griffiths, H. R., Hadjilucas, E., Juvonen, K., Lahtinen, S., Lansink, M., et al. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.792772 · Cited by 255
Meta-analysis: metformin treatment in persons at risk for diabetes mellitus
Salpeter, S. R., Buckley, N. S., Kahn, J. A., & Salpeter, E. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.09.016 · Cited by 248
Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
Scognamiglio, R., Negut, C., Ramondo, A., Tiengo, A., & Avogaro, A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.008 · Cited by 249
Brownrigg, J. R. W., Hughes, C. O., Burleigh, D., Karthikesalingam, A., Patterson, B. O., Holt, P. J., Thompson, M. M., de Lusignan, S., Ray, K. K., & Hinchliffe, R. J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30057-2 · Cited by 242
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243
Biologic and Quality-of-Life Outcomes From the Mediterranean Lifestyle Program
Toobert, D. J., Glasgow, R. E., Strycker, L. A., Barrera, M., Radcliffe, J. L., Wander, R. C., & Bagdade, J. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2288 · Cited by 238
Cho, E., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02044-2 · Cited by 225
Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.10.007 · Cited by 232
Chahil, T. J., & Ginsberg, H. N. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.002 · Cited by 233
Goff, D. C., Gerstein, H. C., Ginsberg, H. N., Cushman, W. C., Margolis, K. L., Byington, R. P., Buse, J. B., Genuth, S., Probstfield, J. L., & Simons-Morton, D. G. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.002 · Cited by 229
Gender-specific care of the patient with diabetes: review and recommendations
Legato, M. J., Gelzer, A., Goland, R., Ebner, S. A., Rajan, S., Villagra, V., & Kosowski, M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80202-0 · Cited by 225
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
Niskanen, L., Hedner, T., Hansson, L., Lanke, J., Niklason, A., & for the CAPPP study group (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2091 · Cited by 219
Malik, S., Zhao, Y., Budoff, M., Nasir, K., Blumenthal, R. S., Bertoni, A. G., & Wong, N. D. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4191 · Cited by 215
Guo, F., Moellering, D. R., & Garvey, W. T. (2014) · Obesity · doi:10.1002/oby.20585 · Cited by 202
Chiavaroli, L., Lee, D., Ahmed, A., Cheung, A., Khan, T. A., Blanco, S., Mejia, Mirrahimi, A., Jenkins, D. J. A., Livesey, G., et al. (2021) · BMJ · doi:10.1136/bmj.n1651 · Cited by 215
Coronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.001 · Cited by 222
Exercise training improves baroreflex sensitivity in type 2 diabetes
Loimaala, A., Huikuri, H. V., Kööbi, T., Rinne, M., Nenonen, A., & Vuori, I. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1837 · Cited by 207
Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina
Kosiborod, M., Arnold, S. V., Spertus, J. A., McGuire, D. K., Li, Y., Yue, P., Ben-Yehuda, O., Katz, A., Jones, P. G., Olmsted, A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.011 · Cited by 205
Nielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.78 · Cited by 207
Viguiliouk, E., Kendall, C. W., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Choo, V. L., Mejia, S. B., Stewart, S. E., Leiter, L. A., Jenkins, D. J., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.032 · Cited by 201
Smooke, S., Horwich, T. B., & Fonarow, G. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.005 · Cited by 196
Nuts and coronary heart disease: an epidemiological perspective
Kelly, J. H., & Sabaté, J. (2006) · British Journal of Nutrition · doi:10.1017/bjn20061865 · Cited by 193
Combination therapy with GLP ‐1 receptor agonist and SGLT2 inhibitor
DeFronzo, R. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12982 · Cited by 192
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure
de Groote, P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.010 · Cited by 192
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
Self-citationGlueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T. R., Weber, K., Illig, E., Streicher, P., Sieve-Smith, L., Tracy, T. M., Lang, J. E., et al. (2001) · Metabolism · doi:10.1053/meta.2001.24192 · Cited by 188
Elam, M. B., Ginsberg, H. N., Lovato, L. C., Corson, M., Largay, J., Leiter, L. A., Lopez, C., O’Connor, P. J., Sweeney, M. E., Weiss, D., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4828 · Cited by 185
The renin–angiotensin–aldosterone system and glucose homeostasis
Luther, J. M., & Brown, N. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.07.006 · Cited by 185
Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors
Howard, B. V., Best, L. G., Galloway, J. M., Howard, W. J., Jones, K., Lee, E. T., Ratner, R. E., Resnick, H. E., & Devereux, R. B. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1299 · Cited by 180
C-Reactive Protein and Incident Cardiovascular Events Among Men With Diabetes
Schulze, M. B., Rimm, E. B., Li, T., Rifai, N., Stampfer, M. J., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.889 · Cited by 180
Depression and coronary heart disease in women with diabetes
Clouse, R. E., Lustman, P. J., Freedland, K. E., Griffith, L. S., McGill, J. B., & Carney, R. M. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000041624.96580.1f · Cited by 179
Mozaffarian, D., Marfisi, R., Levantesi, G., Silletta, M. G., Tavazzi, L., Tognoni, G., Valagussa, F., & Marchioli, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61343-9 · Cited by 179
Hu, G., Jousilahti, P., Qiao, Q., Katoh, S., & Tuomilehto, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1730-6 · Cited by 176
Cardiovascular risk assessment scores for people with diabetes: a systematic review
Chamnan, P., Simmons, R. K., Sharp, S. J., Griffin, S. J., & Wareham, N. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1454-0 · Cited by 176
Schwartz, E. A., Koska, J., Mullin, M. P., Syoufi, I., Schwenke, D. C., & Reaven, P. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.028 · Cited by 173
The Inflammasome in Atherosclerosis and Type 2 Diabetes
Masters, S. L., Latz, E., & O’Neill, L. A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001902 · Cited by 169
Metformin improves vascular function in insulin-resistant rats
Katakam, P. V. G., Ujhelyi, M. R., Hoenig, M., & Miller, A. W. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.108 · Cited by 167
Recent trends in cardiovascular complications among men and women with and without diabetes
Booth, G. L., Kapral, M. K., Fung, K., & Tu, J. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-0776 · Cited by 171
Revisiting the links between glycaemia, diabetes and cardiovascular disease
Sattar, N. (2013) · Diabetologia · doi:10.1007/s00125-012-2817-5 · Cited by 163
Effect of pravastatin in people with diabetes and chronic kidney disease
Tonelli, M., Keech, A., Shepherd, J., Sacks, F., Tonkin, A., Packard, C., Pfeffer, M., Simes, J., Isles, C., Furberg, C., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070779 · Cited by 159
Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1589 · Cited by 164
Langsted, A., & Nordestgaard, B. G. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157164 · Cited by 160
Calles-Escandón, J., Lovato, L. C., Simons-Morton, D. G., Kendall, D. M., Pop-Busui, R., Cohen, R. M., Bonds, D. E., Fonseca, V. A., Ismail-Beigi, F., Banerji, M. A., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1471 · Cited by 160
Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
Brunzell, J. D., & Ayyobi, A. F. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.011 · Cited by 155
Bray, G. A. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.031 · Cited by 158
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Saraiva, F. K., & Sposito, A. C. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0142-7 · Cited by 143
MacIntyre, P., Fisher, M., Kirk, A., & Mutrie, N. (2004) · Diabetologia · doi:10.1007/s00125-004-1396-5 · Cited by 139
Approaches to prevention of cardiovascular complications and events in diabetes mellitus
Coccheri, S. (2007) · Drugs · doi:10.2165/00003495-200767070-00005 · Cited by 139
Koppes, L. L. J., Dekker, J. M., Hendriks, H. F. J., Bouter, L. M., & Heine, R. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0127-x · Cited by 136
Burger, K. N. J., Beulens, J. W. J., van der Schouw, Y. T., Sluijs, I., Spijkerman, A. M. W., Sluik, D., Boeing, H., Kaaks, R., Teucher, B., Dethlefsen, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043127 · Cited by 131
Perreault, L., Temprosa, M., Mather, K. J., Horton, E., Kitabchi, A., Larkin, M., Montez, M. G., Thayer, D., Orchard, T. J., Hamman, R. F., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0656 · Cited by 131
Subherwal, S., Patel, M. R., Kober, L., Peterson, E. D., Bhatt, D. L., Gislason, G. H., Olsen, A.-M. S., Jones, W. S., Torp-Pedersen, C., & Fosbol, E. L. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487313519344 · Cited by 129
Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management
El-Atat, F., McFarlane, S. I., & Sowers, J. R. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0072-y · Cited by 121
NF‐κB as the mediator of metformin's effect on ageing and ageing‐related diseases
Kanigur Sultuybek, G., Soydas, T., & Yenmis, G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13073 · Cited by 119
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance
Sasso, F. C. (2004) · JAMA · doi:10.1001/jama.291.15.1857 · Cited by 117
Lipid modification in type 2 diabetes: the role of LDL and HDL
Vergès, B. (2009) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00739.x · Cited by 117
Insulin Resistance and Risk of Incident Heart Failure: Cardiovascular Health Study
Banerjee, D., Biggs, M. L., Mercer, L., Mukamal, K., Kaplan, R., Barzilay, J., Kuller, L., Kizer, J. R., Djousse, L., Tracy, R., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000022 · Cited by 105
Shah, S., Iqbal, M., Karam, J., Salifu, M., & McFarlane, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1629 · Cited by 115
Oldridge, N. B., Stump, T. E., Nothwehr, F. K., & Clark, D. O. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00350-x · Cited by 113
Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes
Severson, D. L. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-065 · Cited by 111
Myocardial infarction and heart failure in the db/db diabetic mouse
Greer, J. J. M., Ware, D. P., & Lefer, D. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00583.2005 · Cited by 108
Ding, H., Aljofan, M., & Triggle, C. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21063 · Cited by 107
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Mundil, D., Cameron-Vendrig, A., & Husain, M. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441526 · Cited by 104
Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus.
Nojima, H., Watanabe, H., Yamane, K., Kitahara, Y., Sekikawa, K., Yamamoto, H., Yokoyama, A., Inamizu, T., Asahara, T., & Kohno, N. (2008) · Metabolism · doi:10.1016/j.metabol.2007.08.021 · Cited by 102
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Kalyani, R. R. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2000280 · Cited by 101
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines9010003 · Cited by 97
He, Z., Opland, D. M., Way, K. J., Ueki, K., Bodyak, N., Kang, P. M., Izumo, S., Kulkarni, R. N., Wang, B., Liao, R., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209500.15801.4e · Cited by 94
Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.074 · Cited by 91
Sargen, M. R., Hoffstad, O., & Margolis, D. J. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.003 · Cited by 93
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region
(2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280dce59e · Cited by 94
Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0013 · Cited by 91
Effects of pioglitazone on lipid and lipoprotein metabolism.
Betteridge, D. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00715.x · Cited by 91
Shi, L., Ji, Y., Jiang, X., Zhou, L., Xu, Y., Li, Y., Jiang, W., Meng, P., & Liu, X. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0177-4 · Cited by 91
Paneni, F., & Lüscher, T. F. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.015 · Cited by 83
Straka, R. J., Liu, L. Z., Girase, P. S., DeLorenzo, A., & Chapman, R. H. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-53 · Cited by 67
Krempf, M., Parhofer, K. G., Steg, P. G., Bhatt, D. L., Ohman, E. M., Röther, J., Goto, S., Pasquet, B., & Wilson, P. W. F. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.048 · Cited by 82
Holman, R. R., Paul, S., Farmer, A., Tucker, L., Stratton, I. M., Neil, H. A. W., & on behalf of the AFORRD study group (2009) · Diabetologia · doi:10.1007/s00125-008-1179-5 · Cited by 81
Pearce, K. L., Noakes, M., Keogh, J., & Clifton, P. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.638 · Cited by 80
Wang, P., & Chatham, J. C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00295.2003 · Cited by 81
Zhou, Y., Huang, Y., Ji, X., Wang, X., Shen, L., & Wang, Y. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz252 · Cited by 81
Cavender, M. A., Scirica, B. M., Bonaca, M. P., Angiolillo, D. J., Dalby, A. J., Dellborg, M., Morais, J., Murphy, S. A., Ophuis, T. O., Tendera, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013774 · Cited by 80
Hafstad, A. D., Khalid, A. M., How, O.-J., Larsen, T. S., & Aasum, E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2006 · Cited by 79
Results of cardiac rehabilitation in patients with diabetes mellitus
Banzer, J. A., Maguire, T. E., Kennedy, C. M., O'Malley, C. J., & Balady, G. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.017 · Cited by 78
Diabetes and Coronary Heart Disease as Risk Factors for Mortality in Older Adults
Carnethon, M. R., Biggs, M. L., Barzilay, J., Kuller, L. H., Mozaffarian, D., Mukamal, K., Smith, N. L., & Siscovick, D. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.023 · Cited by 77
Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study
Kucharska-Newton, A. M., Couper, D. J., Pankow, J. S., Prineas, R. J., Rea, T. D., Sotoodehnia, N., Chakravarti, A., Folsom, A. R., Siscovick, D. S., & Rosamond, W. D. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0157-9 · Cited by 73
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Sharma, A., Coles, A., Sekaran, N. K., Pagidipati, N. J., Lu, M. T., Mark, D. B., Lee, K. L., Al-Khalidi, H. R., Hoffmann, U., & Douglas, P. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.056 · Cited by 72
Liu, Y., Cotillard, A., Vatier, C., Bastard, J.-P., Fellahi, S., Stévant, M., Allatif, O., Langlois, C., Bieuvelet, S., Brochot, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138646 · Cited by 71
American Diabetes Association Indications for Statins in Diabetes
Eldor, R., & Raz, I. (2009) · Diabetes Care · doi:10.2337/dc09-s345 · Cited by 71
Zaman, A. K. M. T., Fujii, S., Goto, D., Furumoto, T., Mishima, T., Nakai, Y., Dong, J., Imagawa, S., Sobel, B. E., & Kitabatake, A. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.006 · Cited by 70
Sattar, N., Presslie, C., Rutter, M. K., & McGuire, D. K. (2024) · Diabetes Care · doi:10.2337/dci23-0041 · Cited by 70
Zaman, A. K. M. T., Fujii, S., Sawa, H., Goto, D., Ishimori, N., Watano, K., Kaneko, T., Furumoto, T., Sugawara, T., Sakuma, I., et al. (2001) · Circulation · doi:10.1161/01.cir.103.25.3123 · Cited by 68
Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes
Clarke, G. D., Solis-Herrera, C., Molina-Wilkins, M., Martinez, S., Merovci, A., Cersosimo, E., Chilton, R. J., Iozzo, P., Gastaldelli, A., Abdul-Ghani, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0078 · Cited by 63
Takara, A., Ogawa, H., Endoh, Y., Mori, F., Yamaguchi, J.-I., Takagi, A., Koyanagi, R., Shiga, T., Kasanuki, H., & Hagiwara, N. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-1 · Cited by 61
Karjalainen, J. J., Kiviniemi, A. M., Hautala, A. J., Piira, O.-P., Lepojärvi, E. S., Perkiömäki, J. S., Junttila, M. J., Huikuri, H. V., & Tulppo, M. P. (2015) · Diabetes Care · doi:10.2337/dc14-2216 · Cited by 60
Armstrong, M. J., Sigal, R. J., Arena, R., Hauer, T. L., Austford, L. D., Aggarwal, S., Stone, J. A., & Martin, B.-J. (2015) · Diabetologia · doi:10.1007/s00125-015-3491-1 · Cited by 60
Dilley, J., Ganesan, A., Deepa, R., Deepa, M., Sharada, G., Williams, O. D., & Mohan, V. (2007) · Diabetes Care · doi:10.2337/dc06-2414 · Cited by 58
Hyre, A. D., Fox, C. S., Astor, B. C., Cohen, A. J., & Muntner, P. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.09.017 · Cited by 55
Type 2 diabetes and cardiovascular disease: what next?
Joseph, J. J., & Golden, S. H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000044 · Cited by 57
Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Petit, J. M., Degrace, P., & Demizieux, L. (2021) · Diabetes Care · doi:10.2337/dc20-1843 · Cited by 54
Metadata
- Authors
- Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- University of Eastern Finland (FI)
- University of Turku (FI)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1998-07-23
- Volume
- 339
- Issue
- 4
- Pages
- 229-234
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331274940
- Cited by
- 7,000
- References
- 23
- Citations by year
- 2026: 59 · 2025: 82 · 2024: 103 · 2023: 145 · 2022: 152 · 2021: 190 · 2020: 217 · 2019: 255 · 2018: 195 · 2017: 262 · 2016: 232 · 2015: 295 · 2014: 289 · 2013: 337 · 2012: 367
- FWCI
- 88.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, coronary heart disease mortality, myocardial infarction incidence, cardiovascular risk factors, cardiovascular risk stratification, old myocardial infarction, total cholesterol, hypertension, smoking, diabetes and cardiovascular risk
- MeSH terms
- Coronary Disease, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Finland, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Incidence, Proportional Hazards Models, Survival Analysis, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
